Hanmi Pharm. Co., Ltd. Logo

Hanmi Pharm. Co., Ltd.

Biopharma firm developing innovative diabetes and cancer drugs for patients and professionals.

128940 | KO

Overview

Corporate Details

ISIN(s):
KR7128940004
LEI:
Country:
South Korea
Address:
경기도 화성시 팔탄면 무하로 214, 화성시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Hanmi Pharmaceutical Co., Ltd., established in 1973, is a leading South Korean biopharmaceutical company with a strong focus on research and development. The company develops, manufactures, and markets a broad portfolio of in-house medicines, including prescription drugs, over-the-counter (OTC) products, medical supplies, and raw materials. Hanmi is recognized for its innovative drug development, particularly in the therapeutic areas of diabetes and cancer, and is committed to providing advanced medical solutions to healthcare professionals and patients.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-16 00:00
Report Publication Announcement
기업설명회(IR)개최(안내공시)
Korean 6.1 KB
2025-09-03 00:00
Regulatory News Service
[기재정정]투자판단관련주요경영사항
Korean 13.3 KB
2025-09-01 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 46.4 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 3.4 MB
2025-08-14 00:00
Interim Report
[기재정정]반기보고서 (2025.06)
Korean 3.5 MB
2025-08-01 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 59.1 KB
2025-08-01 00:00
Governance Information
공정거래자율준수프로그램운영현황(안내공시)
Korean 31.0 KB
2025-07-28 00:00
Report Publication Announcement
기업설명회(IR)개최(안내공시)
Korean 6.0 KB
2025-07-25 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 15.5 KB
2025-07-25 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 92.2 KB
2025-07-18 00:00
Report Publication Announcement
결산실적공시예고(안내공시)
Korean 4.4 KB
2025-07-18 00:00
Report Publication Announcement
기업설명회(IR)개최(안내공시)
Korean 6.1 KB
2025-07-02 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 53.2 KB
2025-07-01 00:00
Report Publication Announcement
기업설명회(IR)개최(안내공시)
Korean 6.1 KB
2025-06-02 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 72.8 KB

Automate Your Workflow. Get a real-time feed of all Hanmi Pharm. Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Hanmi Pharm. Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Hanmi Pharm. Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Olema Pharmaceuticals, Inc. Logo
A clinical-stage biopharma developing targeted therapies for women's cancers, focusing on breast cancer.
United States of America
OLMA
OliX Pharmaceuticals, Inc. Logo
Developing RNAi therapeutics for dermatology, ophthalmology, and metabolic diseases via an asiRNA platform.
South Korea
226950
OMEROS CORP Logo
Develops first-in-class therapeutics for challenging diseases with unmet medical needs.
United States of America
OMER
ONCODESIGN Logo
Developing precision oncology solutions for resistant and metastatic cancers.
France
ALONC
Oncodesign Precision Medicine S.A Logo
Develops precision therapies & diagnostics for resistant and metastatic cancers.
France
ALOPM
Oncoinvent ASA Logo
Developing alpha-emitting radiotherapies for treating cancers in the peritoneal cavity.
Norway
OCIN
Oncolys BioPharma Inc. Logo
Developing oncolytic virus therapies and diagnostics for cancer and serious viral infections.
Japan
4588
ONCOLYTICS BIOTECH INC Logo
Developing an immuno-oncolytic virus to treat breast and gastrointestinal cancers.
United States of America
ONCY
Onconetix, Inc. Logo
Develops diagnostics and therapeutics for men's health and oncology markets.
United States of America
ONCO
Oncopeptides Logo
Develops targeted therapies for hematological cancers using peptide-drug conjugate technology.
Sweden
ONCO

Talk to a Data Expert

Have a question? We'll get back to you promptly.